Metabolic changes of cancer cachexia - Second of two parts

Clinical Nutrition

Volumn 16, Issue 5, 1997, Pages 223-228

  De Blaauw, I ^a   Deutz, N E P ^a   Von Meyenfeldt, M F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CACHEXIA; CANCER; HORMONAL REGULATION; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; MEDIATOR RELEASE; METABOLISM; NONHUMAN; NUTRIENT; REVIEW; TISSUE METABOLISM;

EID: 0031457829     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(97)80033-7     Document Type: Review

References (48)

1. Kern K A, Norton J A. Cancer cachexia. J Parenter Enteral Nutr 1988; 12: 286-298
2. Illig K A, Maronian N, Peacock J L. Cancer cachexia is transmissible in plasma. J Surg Res 1984; 52: 353-358
3. Norton J A, Moley J F, Green M V, Carson R E, Morrison S D. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res 1985; 45: 5547-5552
4. Devereux D F, Redgrave T G, Loda M F, Clowes G H Jr, Deckers P J. Tumor-associated metabolism in the rat is a unique physiologic entity. J Surg Res 1985; 38: 149-153
5. Yoneda T, Alsina M A, Chavez J B, Bonewald L, Nishimura R, Mundy G R. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J Clin Invest 1991; 87: 977-985
6. Flores E, Bistrian B, Pomposelli J, Dinarello C, Blackburn G, Istfan N. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest 1989; 83: 1614-1622
7. Tracey K J, Wei H, Manogue K R et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988; 167: 1211-1227
8. Tracey K J, Lowry S F, Fahey T J III et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surgical Gynecology and Obstetrics 1987; 164: 415-422
9. Gelin J, Moldawer L L, Lonnroth C, Sherry B, Chizzonite R, Lundholm K. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991; 51: 415-421
10. Fong Y, Moldawer L L, Marano M et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 1989; 256: R659-R665
11. Kawakami M, Cerami A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981; 154: 631-639
12. Greenberg A S, Nordan R P, McIntosh J, Calvo J C, Scow R O, Tablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992; 52: 4113-4116
13. Fried S K, Zechner R. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 1989; 30: 1917-1923
14. Zechner R, Newman T C, Sherry B, Cerami A, Breslow J L. Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes. Mol Cell Biol 1988; 8: 2394-2401
15. Evans D A, Jacobs D O, Wilmore D W. Effects of tumour necrosis factor on protein metabolism. Br J Surg 1993; 80: 1019-1023
16. Sakurai Y, Zhang X J, Wolfe R R. Short-term effects of tumor necrosis factor on energy and substrate metabolism in dogs. J Clin Invest 1993; 91: 2437-2445
17. Starnes H F, Warren R S, Jeevanandam M et at. Tumor Necrosis Factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321-1325
18. Van der Poll T, Romijn J A, Endert E, Borm J J, Buller H R, Sauerwein H P. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991; 261: E457-E465
19. Lahdevirta J, Maury C P, Teppo A M, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289-291
20. Grau G E, Taylor T E, Molyneux M E et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320: 1586-1591
21. Stovroff M C, Fraker D L, Norton J A. Cachectin activity in the serum of cachectic, tumour-bearing rats. Arch Surg 1989; 124: 94-99
22. Tessitore L, Costelli P, Baccino F M. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer 1993; 67: 15-23
23. Smith B K, Conn C A, Kluger M J. Experimental cachexia: effects of MCA sarcoma in the Fischer rat. Am J Physiol 1993; 265: E376-E384
24. Strassmann G, Fong M, Kenney J S, Jacob C O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681-1684
25. Langstein H N, Doherty G M, Fraker D L, Buresh C M, Norton J A. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia. Cancer Res 1991; 51: 2302-2306
26. Tomas F M, Chandler C S, Coyle P, Bourgeois C S, Burgoyne J L, Rofe A M. Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats. Biochem J 1994; 301: 769-775
27. Balkwill F, Osborne R, Burke F et al. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 1987; (ii): 1229-1232
28. Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer 1992; 70: 709-713
29. Elsasser-Beile U, Von Kleist S, Stahle W et al. Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma. Cancer 1993; 71: 231-236
30. Falconer J S, Fearon K C H, Plester C E, Ross J A, Carter D C. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325-331
31. Selby P J, Hobbs S, Viner C, Jackson E, Smith I E, McElwain T J. Endogenous tumour necrosis factor in cancer patients. Lancet 1988; (i): 483-485
32. Socher S H, Martinez D, Craig J B, Kuhn J G, Oliff A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 1988; 80: 595-598
33. Costelli P, Carbo N, Tessitore L et al. Tumor Necrosis Factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993; 92: 2783-2789
34. Sherry B A, Gelin J, Fong Y et al. Anticachectin/tumor necrosis factor-a antibodies attenuate development of cachexia in tumor models. FASEB J 1989; 3: 1956-1962
35. Lonnroth C, Gelin J, Lundholm K. Expression of interleukin-6 in tumor bearing mice with cytokine dependent cachexia. Int J Oncol 1994; 5: 329-336
36. Lonnroth C, Moldawer L L, Gelin J, Kindblom L, Sherry B, Lundholm K. Tumor necrosis factor-alpha and interleukin-1 alpha production in cachectic, tumor-bearing mice. Int J Cancer 1990; 46: 889-896
37. Tracey K J, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; (i): 1122-1126
38. Fearon K C H, McMillan D C, Preston T, Winstanley P, Cruickshank A M, Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991; 213: 26-31
39. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanism of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol 1993; 150: 2341-2345
40. Strassmann G, Kambayashi T. Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy. Cytokines and Molecular Therapy 1995; 1(2): 107-113.
41. Grande F, Anderson J T, Keys A. Changes of basal metabolic rate in man in semistarvation and refeeding. J Appl Physiol 1958; 12(2): 230-238
42. Strassmann G, Fong M, Freter C E, Winder S, D'Alessandro F, Nordan R P. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J Clin Invest 1993; 92: 2152-2159
43. Oldenburg H S, Rogy M A, Lazarus D D et al. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 1993; 23: 1889-1894
44. Jablons D M, Mule J J, McIntosh J K et al. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989; 142: 1542-1547
45. Bereta J, Kurdowska A, Koj A et al. Different preparations of natural and recombinant human interleukin-6 (IFN-beta 2, BSF-2) similarly stimulate acute phase protein synthesis and uptake of alpha-aminoisobutyric acid by cultured rat hepatocytes. Int J Biochem 1989; 21: 361-366
46. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717-721
47. Andersson C, Gelin J, Iresjo B M, Lundholm K. Acute-phase proteins in response to tumor growth. J Surg Res 1993; 55: 607-614
48. McIntosh J K, Jablons D M, Mule J J et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol 1989; 143: 162-167